https://msra.org.au/news/fda-approves-a ... treatment/
very good news that medication CLADRINE ALSSO CALLED MAVENCLAD approved by FDA for treatment of
Secondary Progressive M.S. this edition already been approved
by the TGA AND added to PBS for RRMS from 1 January 2019 a possibility soon this medication in AUSTRALIA will be revised and extended to include active secondary progressive m.s.
- Similar Topics
- Last post